UTHR Dividend History & Analysis | 0% Yield
UTHR has a dividend yield of 0% and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| EPIX | 91 M | 172% | 24.1% |
| ABBV | 370,094 M | 3.26% | 8.26% |
| GILD | 144,108 M | 2.90% | 5.71% |
| NOVO-B | 240,349 M | 2.52% | 5.99% |
| AMGN | 159,226 M | 3.25% | 4.34% |
| Symbol | Market Cap (USD) | Growth Rate (5y CAGR) | Payout Consistency |
|---|---|---|---|
| NOVO-B | 240,349 M | 35.7% | 74.9% |
| BIOG-B | 1,011 M | 20.4% | 95.9% |
| GRFS | 8,406 M | 50.6% | 60.7% |
| SECARE | 655 M | 10.4% | 100% |
| AMGN | 159,226 M | 7.06% | 100% |
Similar Stocks with Attractive Dividends - Compare UTHR Dividends with its Peer-Group
3.26% Yield
3.25% Yield
2.90% Yield
2.52% Yield
1.81% Yield
UTHR Dividend History: as of September 2025
No dividends paid yet.UTHR Dividend FAQ
United Therapeutics Corporation is a biotechnology company that develops and commercializes products for chronic and life-threatening diseases. The companys product portfolio includes treatments for pulmonary arterial hypertension (PAH) such as Tyvaso DPI, Tyvaso, Remodulin, Orenitram, and Adcirca, as well as Unituxin for high-risk neuroblastoma. The companys pipeline includes RemoPro, Ralinepag, Aurora-GT gene therapy, and Nebulized Tyvaso for idiopathic pulmonary fibrosis.
What is the Dividend Yield of UTHR?
As of September 2025, UTHR`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 304.76.Does UTHR pay a dividend?
As of September 2025 UTHR does not pay a dividend.How often does UTHR pay dividends?
Over the last 12 months, UTHR has issued dividend payments.Will UTHR pay dividends in 2025?
The next Ex-Dividend date for United Therapeutics (UTHR) is currently unknown.What is the next Ex-Dividend Date for UTHR?
The next Ex-Dividend date for United Therapeutics (UTHR) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of UTHR?
UTHR's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of UTHR?
UTHR's 5-Year Yield on Cost is -%. If you bought UTHR's shares at 106.96 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of UTHR?
UTHR Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does UTHR have a good Dividend Yield?
UTHR`s 0.00% Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of UTHR?
The Dividend Payout Ratio of UTHR is unknown.What is the Dividend Rating of UTHR?
UTHR`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-08-06 02:53